|1.||Strobl, Jeannine S: 2 articles (02/2009 - 11/2004)|
|2.||Rathore, Dharmendar: 1 article (02/2009)|
|3.||Li, Yunbo: 1 article (02/2009)|
|4.||Mitchell, Sheila M: 1 article (02/2009)|
|5.||Rosypal, Alexa C: 1 article (02/2009)|
|6.||Nagarkatti, Rana: 1 article (02/2009)|
|7.||Lindsay, David S: 1 article (02/2009)|
|8.||Seibert, Christopher W: 1 article (02/2009)|
|9.||Martirosyan, Anna: 1 article (05/2006)|
|10.||Griffith, Brian: 1 article (05/2006)|
02/01/2009 - "Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent."
05/01/2006 - "Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells."
|2.||Breast Neoplasms (Breast Cancer)
05/01/2006 - "We investigated the mechanism of NSC3852 action in MCF-7 human breast cancer cells using electron spin resonance (ESR). "
05/01/2006 - "NSC3852 (5-nitroso-8-quinolinol) has cell differentiation and antiproliferative activity in human breast cancer cells in tissue culture and antitumor activity in mice bearing P388 and L1210 leukemic cells. "
11/01/2004 - "The physicochemical properties of NSC3852, NSC69603, NSC86371, and NSC305819 predicted they are drug candidates suitable for development as experimental breast tumor cell differentiation agents. "
|1.||Histone Deacetylase Inhibitors
|2.||Reactive Oxygen Species (Oxygen Radicals)